An Open-label Adrenal Suppression Study of 0.1% Fluocinonide Cream in Pediatric Patients With Atopic Dermatitis

OBJECTIVE To assess the potential of a superhigh-potency 0.1% fluocinonide cream to suppress the hypothalamic-pituitary-adrenal (HPA) axis in pediatric patients with atopic dermatitis. DESIGN A multicenter, multiple-dose, open-label safety study in 4 age cohorts with 0.1% fluocinonide cream applied...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of dermatology (1960) 2006-12, Vol.142 (12), p.1568-1572
Hauptverfasser:	Schlessinger, Joel, Miller, Bruce, Gilbert, Richard D, Plott, R. Todd
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Allergic diseases Anti-Allergic Agents - administration & dosage Anti-Allergic Agents - therapeutic use Biological and medical sciences Child Child, Preschool Dermatitis Dermatitis, Atopic - blood Dermatitis, Atopic - drug therapy Dermatitis, Atopic - pathology Dermatology Dose-Response Relationship, Drug Female Fluocinonide - administration & dosage Fluocinonide - therapeutic use Follow-Up Studies Humans Hydrocortisone - blood Hypothalamo-Hypophyseal System - drug effects Immunopathology Infant Male Medical sciences Ointments Pediatrics Pituitary-Adrenal System - drug effects Severity of Illness Index Skin allergic diseases. Stinging insect allergies Skin care products Skin diseases Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!